--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
--------------------------------------------------------------------------------
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: May 5, 2004
Date of Earliest Event Reported: May 5, 2004
MILLENNIUM CHEMICALS INC.
(Exact name of registrant as specified in its charter)
Delaware 1-12091 22-3436215
(State or other jurisdiction of (I.R.S. Employer Identification Number)
incorporation or organization) (Commission File Number)
20 Wight Avenue, Suite 100
Hunt Valley, Maryland 21030
(Address of principal executive offices)
Registrant's telephone number, including area code: (410) 229-4400
--------------------------------------------------------------------------------
Item 9. Regulation FD Disclosure.
On May 5, 2004, Millennium Chemicals announced the postponement of
its previously announced conference call on first quarter operating results and
outlook scheduled for 1:00 p.m. on May 5, 2004. The postponement of the call and
the issuance of first quarter operating results is necessary to provide
Millennium with additional time to analyze the potential accounting
ramifications of revised FASB Interpretation No. 46, Consolidation of Variable
Interest Entities. Millennium's May 5, 2004 press release regarding the
postponement of the earnings release and conference call and the provision of
information on first quarter results is being furnished with this Current Report
on Form 8-K as Exhibit 99.1. The foregoing press release shall not be deemed to
be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or
otherwise subject to the liabilities of that Section.
Exhibit Description
------- -----------
99.1 Press Release issued May 5, 2004
Item 12. Results of Operations and Financial Condition.
This press release is being furnished pursuant to Item 9 and
Item 12.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on behalf of the undersigned
hereunto duly authorized.
Dated: May 5, 2004 MILLENNIUM CHEMICALS INC.
By:/C. William Carmean/
-----------------------------------------
C. William Carmean
Senior Vice President, General Counsel &
Secretary
EXHIBIT INDEX
Exhibit Description
------- -----------
99.1 Press release issued May 5, 2004
STATEMENT OF DIFFERENCES
Characters normally expressed as subscript shall be preceded by..............[u]